Balchem buys Italian feed ingredients firm

By Jane Byrne contact

- Last updated on GMT

© GettyImages
© GettyImages
Balchem Corporation, through its wholly owned subsidiary, Balchem Italia, has announced the acquisition of Bioscreen Technologies, a small privately held manufacturer of encapsulated and fermented feed nutrition ingredients, headquartered in Bertinoro, Italy.

The financial terms of the deal were not disclosed.

Bioscreen, which launched in 2005, manufactures encapsulates and fermented products targeted at animal nutrition and health.  

The US company said Bioscreen's existing business will be integrated within Balchem's animal nutrition and health business segment, which has a focus on encapsulated nutrients, choline products and chelated minerals.

Jonathan Griffin, VP and general manager of Balchem’s animal nutrition and health division said while Bioscreen does not bring significant existing business to Balchem, this acquisition provides a European manufacturing platform for the New York based company’s encapsulated nutrients and will allow it to accelerate its growth within Europe.

The addition of local European manufacturing capabilities for our encapsulated products, to our existing European choline manufacturing footprint, further strengthens our ability to bring a broad range of health and nutrition solutions to our European customers."

Balchem financial results

In its Q2 results released in early August, Balchem reported that its animal nutrition and health segment recorded sales of $42m, which was an increase of $5m or 13.5% compared to the prior year quarter:

“The increased sales were primarily due to higher monogastric species sales, driven by healthy demand in North America and Europe, higher average selling prices, and additional sales realized as a result of the continuing supply disruptions of Chinese imports, partially offset by lower ruminant species sales.

It said second quarter earnings from operations for this segment of $7.1m were $3.4m or 92.8% higher than the prior year comparable quarter of $3.7m, primarily due to those higher monogastric sales volumes and higher average selling prices.

Related news

Show more

Related products

show more

Effects of GroPro in piglet diets - SDPP replacement

Effects of GroPro in piglet diets - SDPP replacement

Angel Yeast Co., Ltd. | 01-Oct-2018 | Technical / White Paper

The use of sprayed dried plasma protein is commonplace in piglet diets worldwide, but an alternative is available in the form of functional yeast - GroPro....

EFSA's new dossier requirements: benefits or pitfalls?

EFSA's new dossier requirements: benefits or pitfalls?

Pen & Tec Consulting Group | 01-Sep-2018 | Technical / White Paper

With various points being modified recently, it is essential that companies are aware of the changes made to the requirements for introducing a new feed...

Related suppliers

Follow us


View more